Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID07108517

A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth Using Acceptance and Commitment Therapy to Enhance Psychosocial Care

Led by Centre for Research and Technology Hellas · Updated on 2025-08-07

180

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

Sponsors

C

Centre for Research and Technology Hellas

Lead Sponsor

A

AHEPA University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are exploring how people with breast, colorectal, and head and neck cancers can experience positive psychological changes called post-traumatic growth (PTG) after their cancer diagnosis and treatment. This project, called IC-Growth, aims to develop and test a new group-based program that helps adults with cancer improve their well-being, resilience, and quality of life beyond their pre-diagnosis levels. The study also seeks to create health policy recommendations to enhance psychosocial support for cancer patients in Greece. The research includes a randomized controlled trial comparing a manualized group intervention with standard follow-up care. The intervention is delivered in groups of 8-10 participants with the same cancer type and consists of 6-8 weekly 90-minute sessions led by trained psychologists. It uses techniques such as Acceptance and Commitment Therapy, mindfulness, cognitive restructuring, narrative exercises, and interpersonal support to promote growth in areas like self-perception, relationships, and life appreciation. The control group receives only standard oncology follow-up care. Participants will complete assessments before and after the intervention, measuring post-traumatic growth, quality of life, spiritual well-being, anxiety, depression, illness perceptions, distress, and stress biomarkers like cortisol. The study lasts about 6-8 weeks for the intervention period, with evaluations at baseline and post-intervention. This comprehensive approach integrates research and health policy to improve psychosocial care and support for people with cancer.

CONDITIONS

Brief Title

A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 to 80 years old
  • Diagnosed with breast cancer, colorectal cancer, or head and neck cancer
  • Completed planned chemotherapy and related hospital admissions
  • Initial cancer diagnosis within the past 5 years
Not Eligible

You will not qualify if you...

  • Currently receiving psychological or psychiatric treatment
  • Having unmanaged mental health difficulties
  • Severe cognitive impairment
  • Unable to provide informed consent
  • Unable to speak or read Greek
  • Experiencing one or more cancer relapses
  • Diagnosed with another type of cancer within the last 5 years
  • Life expectancy less than one year

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 6 to 8 weeks

Participants in the intervention group attend a manualized group-based psychosocial intervention aimed at enhancing post-traumatic growth. The program includes weekly 90-minute sessions incorporating Acceptance and Commitment Therapy, mindfulness, cognitive and narrative exercises, and interpersonal support-building. Participants in the control group continue with standard oncology follow-up care without additional psychosocial intervention.

Weekly visits for 6 to 8 weeks

Follow-up Assessments

Duration - Immediately post-intervention

Participants complete assessments to measure post-traumatic growth, quality of life, spiritual well-being, anxiety, depression, distress, illness perceptions, and salivary cortisol levels at the end of the intervention period.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

AHEPA University Hospital

Thessaloniki, Greece, 54636

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

Investigating The Role of Key Non-coding RNA(s) in Breast Ca...

Breast Cancer

Actively Recruiting

1 location

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Bre...

Breast Cancer

Actively Recruiting

1 location

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here